Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Chronic stress accelerates glioblastoma progression via DRD2/ERK/β-catenin axis and Dopamine/ERK/TH positive feedback loop

Open access
Wang, Yan, Wang, Xiang, Wang, Kai, Qi, Ji, Zhang, Yu, Wang, Xu, Zhang, Long, Zhou, Yi, Gu, Linbo, Yu, Rutong, Zhou, Xiuping · 2023 · Journal of Experimental & Clinical Cancer Research

Abstract

Background: After diagnosis, glioblastoma (GBM) patients undertake tremendous psychological problems such as anxiety and depression, which may contribute to GBM progression. However, systematic study about the relationship between depression and GBM progression is still lacking. Methods: Chronic unpredictable mild stress and chronic restrain stress were used to mimic human depression in mice. Human GBM cells and intracranial GBM model were used to assess the effects of chronic stress on GBM growth. Targeted neurotransmitter sequencing, RNA-seq, immunoblotting and immunohistochemistry were used to detect the related molecular mechanism. Results: Chronic stress promoted GBM progression and up-regulated the level of dopamine (DA) and its receptor type 2 (DRD2) in tumor tissues. Down-regulation or inhibition of DRD2 abolished the promoting effect of chronic stress on GBM progression. Mechanistically, the elevated DA and DRD2 activated ERK1/2 and consequently inhibited GSK3β activity, leading to β-catenin activation. Meanwhile, the activated ERK1/2 up-regulated tyrosine hydroxylase (TH) level in GBM cells and then promoted DA secretion, forming an autocrine positive feedback loop. Remarkably, patients with high-depression exhibited high DRD2 and β-catenin levels, which showed poor prognosis. Additionally, DRD2 specific inhibitor pimozide combined with temozolomide synergistically inhibited GBM growth. Conclusions: Our study revealed that chronic stress accelerates GBM progression via DRD2/ERK/β-catenin axis and Dopamine/ERK/TH positive feedback loop. DRD2 together with β-catenin may serve as a potential predictive biomarker for worse prognosis as well as therapeutic target of GBM patients with depression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13046-023-02728-8

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Chronic stress promotes glioma progression and shortens the survival of nude mice bearing xenografts. A Diagram of the experimental design for nude mice under CUMS or CRS procedure. B&C Body weight (left) and behavioral tests (right) were used to evaluate the depression of mice after CUMS and CRS. D Levels of corticosterone and ACTH in plasma and glioma tissues were measured by ELISA. E&F Representative bioluminescence images (E) and the photon flux was analyzed quantitatively (F) in both models using U87 glioma cells. G Representative H&E staining of consecutive brain sections (left) and the quantified results (right). H Ki67 immunostaining (left) and positive cell quantification (right). I Kaplan–Meier curve showed the overall survival time of glioma-bearing mice. CUMS: chronic unpredictable mild stress. CRS: chronic restraint stress. SPT: sucrose preference test. TST: tail suspension test. *P < 0.05, **P < 0.01, ***P < 0.001
Fig. 1 Chronic stress promotes glioma progression and shortens the survival of nude mice bearing xenografts. A Diagram of the experimental design for nude mice under CUMS or CRS procedure. B&C Body weight (left) and behavioral tests (right) were used to evaluate the depression of mice after CUMS and CRS. D Levels of corticosterone and ACTH in plasma and glioma tissues were measured by ELISA. E&F Representative bioluminescence images (E) and the photon flux was analyzed quantitatively (F) in both models using U87 glioma cells. G Representative H&E staining of consecutive brain sections (left) and the quantified results (right). H Ki67 immunostaining (left) and positive cell quantification (right). I Kaplan–Meier curve showed the overall survival time of glioma-bearing mice. CUMS: chronic unpredictable mild stress. CRS: chronic restraint stress. SPT: sucrose preference test. TST: tail suspension test. *P < 0.05, **P < 0.01, ***P < 0.001CC BY · PubMed Central
Fig. 2 Dopamine and DRD2 levels significantly increased after chronic stress. A-D Heatmap of targeted metabolomic alterations in plasma (A) and glioma tissues (B) after chronic stress and the quantification results (C&D). E&F Levels of two stress-related neurotransmitters (DA and NE) in plasma (E) and glioma tissues (F) were measured by ELISA. G&H Immunoblotting (G) and immunofluorescence staining (H) of TH in glioma tissues with or without chronic stress. Scale bar: 50 μm. I Clustergram of RNA-seq data from tumor tissues of mice. J KEGG analysis of DEGs of RNA-seq data. K Five key genes in dopamine metabolic pathway were significantly upregulated after chronic stress. L The mRNA levels of DRD1 and DRD2 in glioma xenografts. M&N The protein levels of DRD1-5 in xenografts (M) and the quantified results (N). Representative WB of three independent experiment is shown. TH: tyrosine hydroxylase. *P < 0.05, **P < 0.01, ***P < 0.001
Fig. 2 Dopamine and DRD2 levels significantly increased after chronic stress. A-D Heatmap of targeted metabolomic alterations in plasma (A) and glioma tissues (B) after chronic stress and the quantification results (C&D). E&F Levels of two stress-related neurotransmitters (DA and NE) in plasma (E) and glioma tissues (F) were measured by ELISA. G&H Immunoblotting (G) and immunofluorescence staining (H) of TH in glioma tissues with or without chronic stress. Scale bar: 50 μm. I Clustergram of RNA-seq data from tumor tissues of mice. J KEGG analysis of DEGs of RNA-seq data. K Five key genes in dopamine metabolic pathway were significantly upregulated after chronic stress. L The mRNA levels of DRD1 and DRD2 in glioma xenografts. M&N The protein levels of DRD1-5 in xenografts (M) and the quantified results (N). Representative WB of three independent experiment is shown. TH: tyrosine hydroxylase. *P < 0.05, **P < 0.01, ***P < 0.001CC BY · PubMed Central
Fig. 3 DRD2 is required for glioma progression induced by chronic stress. A-D Cell proliferation was measured using CCK-8 (A&B) and EdU assay (C&D) in glioma cells over-expressing or knocking-down DRD2.Scale bar: 100 µm. E–H. Representative images and quantitative results of CCK-8 (E&F) and EdU assay (G&H) of glioma cells knocking-down DRD2 with or without NE (20 μM) treatment. I Diagram of in vivo experimental schedule utilizing GBM#2 glioma cells. J&K Time-lapse bioluminescence imaging of mice (J) and the photon flux was analyzed (K). L Kaplan–Meier curve showed the overall survival time of glioma-bearing mice of each group. NE: norepinephrine. *P < 0.05, **P < 0.01, ***P < 0.001
Fig. 3 DRD2 is required for glioma progression induced by chronic stress. A-D Cell proliferation was measured using CCK-8 (A&B) and EdU assay (C&D) in glioma cells over-expressing or knocking-down DRD2.Scale bar: 100 µm. E–H. Representative images and quantitative results of CCK-8 (E&F) and EdU assay (G&H) of glioma cells knocking-down DRD2 with or without NE (20 μM) treatment. I Diagram of in vivo experimental schedule utilizing GBM#2 glioma cells. J&K Time-lapse bioluminescence imaging of mice (J) and the photon flux was analyzed (K). L Kaplan–Meier curve showed the overall survival time of glioma-bearing mice of each group. NE: norepinephrine. *P < 0.05, **P < 0.01, ***P < 0.001CC BY · PubMed Central
Fig. 4 Chronic stress activates DRD2/ERK/β-catenin axis and Dopamine/ERK/TH regulatory loop. A GSEA was performed using TCGA dataset. B Lysates of glioma tissues after chronic stress were examined by immunoblotting. C Immunofluorescence staining of DRD2 and β-catenin in glioma tissues with or without chronic stress. Scale bar: 50 μm. D Lysates of DRD2 down-regulation or over-expression glioma cells were examined by immunoblotting. E Immunoblotting analysis of DRD2 down-regulated U87 and U251 glioma cells treated with NE. F FpClass analysis predicted that ERK was the protein simultaneously interacting with β-catenin, GSK3β and TH. G Lysates of glioma tissues with or without chronic stress were examined by immunoblotting. H Lysates of DRD2 knockdown U87 and U251 glioma cells treated with both NE and U0126 simultaneously were examined by immunoblotting. WB experiments were independently replicated three times. Act-β-catenin: Active-β-catenin
Fig. 4 Chronic stress activates DRD2/ERK/β-catenin axis and Dopamine/ERK/TH regulatory loop. A GSEA was performed using TCGA dataset. B Lysates of glioma tissues after chronic stress were examined by immunoblotting. C Immunofluorescence staining of DRD2 and β-catenin in glioma tissues with or without chronic stress. Scale bar: 50 μm. D Lysates of DRD2 down-regulation or over-expression glioma cells were examined by immunoblotting. E Immunoblotting analysis of DRD2 down-regulated U87 and U251 glioma cells treated with NE. F FpClass analysis predicted that ERK was the protein simultaneously interacting with β-catenin, GSK3β and TH. G Lysates of glioma tissues with or without chronic stress were examined by immunoblotting. H Lysates of DRD2 knockdown U87 and U251 glioma cells treated with both NE and U0126 simultaneously were examined by immunoblotting. WB experiments were independently replicated three times. Act-β-catenin: Active-β-cateninCC BY · PubMed Central
Fig. 5 DRD2 combined with β-catenin act as an indicator for poor prognosis in GBM patients with depression. A Hamilton scores were gradually upregulated as the advanced malignancy of gliomas. B High-depression GBM patients had a worse prognosis than the patients with low-depression. C&D Glioma lysates from patients with or without depression were subjected to immunoblotting (C) and quantified (D). Representative WB of three independent experiment is shown. E–H Representative images of immunohistochemical staining (E) and percentage (F–H) of DRD2 and β-catenin positive cells in glioma patients with or without depression. Scale bar: 100 μm. I-K Kaplan–Meier survival analysis of glioma patients with or without depression expressing indicated proteins. LGG: low grade glioma. HGG: high grade glioma. *P < 0.05, **P < 0.01, ***P < 0.001
Fig. 5 DRD2 combined with β-catenin act as an indicator for poor prognosis in GBM patients with depression. A Hamilton scores were gradually upregulated as the advanced malignancy of gliomas. B High-depression GBM patients had a worse prognosis than the patients with low-depression. C&D Glioma lysates from patients with or without depression were subjected to immunoblotting (C) and quantified (D). Representative WB of three independent experiment is shown. E–H Representative images of immunohistochemical staining (E) and percentage (F–H) of DRD2 and β-catenin positive cells in glioma patients with or without depression. Scale bar: 100 μm. I-K Kaplan–Meier survival analysis of glioma patients with or without depression expressing indicated proteins. LGG: low grade glioma. HGG: high grade glioma. *P < 0.05, **P < 0.01, ***P < 0.001CC BY · PubMed Central
Fig. 6 Combination treatment of PIMO and TMZ induces a synergistic anti-glioma effect both in vitro and in vivo. A-D Relative proliferation of U251 and U87 cells treated with PIMO (5 μM or 10 μM) and indicated doses of TMZ were measured by CCK-8 assay. E Diagram of in vivo experimental schedule. F&G Representative bioluminescence images of intracranial xenografts using GBM#2 glioma cells with different drug administration on the indicated days (F) and quantitative analysis of the fluorescence index (G). H Kaplan–Meier analysis of the median survival time of nude mice. I Schematic model of how chronic stress promotes glioma growth. PIMO: pimozide. TMZ: Temozolomide. *P < 0.05, **P < 0.01, ***P < 0.001
Fig. 6 Combination treatment of PIMO and TMZ induces a synergistic anti-glioma effect both in vitro and in vivo. A-D Relative proliferation of U251 and U87 cells treated with PIMO (5 μM or 10 μM) and indicated doses of TMZ were measured by CCK-8 assay. E Diagram of in vivo experimental schedule. F&G Representative bioluminescence images of intracranial xenografts using GBM#2 glioma cells with different drug administration on the indicated days (F) and quantitative analysis of the fluorescence index (G). H Kaplan–Meier analysis of the median survival time of nude mice. I Schematic model of how chronic stress promotes glioma growth. PIMO: pimozide. TMZ: Temozolomide. *P < 0.05, **P < 0.01, ***P < 0.001CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 36 references

Cited by

See all 62

Metadata

Authors
Wang, Y., Wang, X., Wang, K., Qi, J., Zhang, Y., Wang, X., Zhang, L., Zhou, Y., Gu, L., Yu, R., & Zhou, X.
Affiliations
Xuzhou Medical College (CN)
Corresponding author
  • Yu, Rutong
  • Zhou, Xiuping
Venue
Journal of Experimental & Clinical Cancer Research
Published
2023-07-07
Volume
42
Issue
1
Pages
161-161
ISSN
  • 0392-9078 (ISSN-L)
  • 1756-9966
OpenAlex
W4383483053
Cited by
55
References
36
Citations by year
2026: 25 · 2025: 24 · 2024: 6
FWCI
11.15
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Experimental & Clinical Cancer Research (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Natural Science Foundation of China (82273111, 82072770, 81902526)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
  • Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Keywords
glioblastoma, chronic stress, depression, DRD2, dopamine, ERK1/2, β-catenin, tyrosine hydroxylase, positive feedback loop, GSK3β, pimozide, temozolomide, prognostic factors
MeSH terms
Animals, Brain Neoplasms, Dopamine, Feedback, Glioblastoma, Humans, Tyrosine 3-Monooxygenase, Receptors, Dopamine D2, Cell Line, Tumor, Cell Proliferation, beta Catenin, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Chronic stress accelerates glioblastoma progression via DRD2/ERK/β-catenin axis and Dopamine/ERK/TH positive feedback loop. https://app.cochat.ai/papers/10.1186/s13046-023-02728-8
The paper
Wang, Y., Wang, X., Wang, K., Qi, J., Zhang, Y., Wang, X., Zhang, L., Zhou, Y., Gu, L., Yu, R., & Zhou, X. (2023). Chronic stress accelerates glioblastoma progression via DRD2/ERK/β-catenin axis and Dopamine/ERK/TH positive feedback loop. Journal of Experimental & Clinical Cancer Research. https://doi.org/10.1186/s13046-023-02728-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.